Complex role for the immune system in initiation and progression of pancreatic cancer

World Journal of Gastroenterology

Volumn 20, Issue 32, 2014, Pages 11160-11181

  Inman, Kristin S ^a   Francis, Amanda A ^a   Murray, Nicole R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Immune system; Immunosuppression; Immunotherapy; Inflammation; Pancreatic ductal adenocarcinoma; Pancreatitis

Indexed keywords

CANCER VACCINE; CYTOKINE;

ACUTE PANCREATITIS; ADAPTIVE IMMUNITY; ANIMAL MODEL; AUTOIMMUNE DISEASE; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER STEM CELL; CELL TYPE; CHRONIC PANCREATITIS; CLINICAL TRIAL (TOPIC); EPITHELIUM CELL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INFLAMMATION; INFLAMMATORY CELL; INNATE IMMUNITY; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREATITIS; REVIEW; STROMA; STROMA CELL; ANIMAL; CARCINOMA, PANCREATIC DUCTAL; CELL TRANSFORMATION; DISEASE COURSE; IMMUNOLOGY; METABOLISM; PANCREATIC NEOPLASMS; PATHOLOGY; PROCEDURES; SIGNAL TRANSDUCTION;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; HUMANS; IMMUNOTHERAPY; PANCREATIC NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84909606805     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i32.11160     Document Type: Review

References (251)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30 [PMID: 23335087 DOI: 10.3322/caac.21166]
2. Evans A, Costello E. The role of inflammatory cells in fostering pancreatic cancer cell growth and invasion. Front Physiol 2012; 3: 270 [PMID: 22969725 DOI: 10.3389/fphys.2012.00270]
3. American Cancer Society. Cancer Facts and Figures 2013. Atlanta: American Cancer Society, 2013
4. Raimondi S, Lowenfels AB, Morselli-Labate AM, Maisonneuve P, Pezzilli R. Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection. Best Pract Res Clin Gastroenterol 2010; 24: 349-358 [PMID: 20510834 DOI: 10.1016/j.bpg.2010.02.007]
5. Liou GY, Döppler H, Necela B, Krishna M, Crawford HC, Raimondo M, Storz P. Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-κB and MMPs. J Cell Biol 2013; 202: 563-577 [PMID: 23918941 DOI: 10.1083/jcb.201301001]
6. Clark CE, Hingorani SR, Mick R, Combs C, Tuveson DA, Vonderheide RH. Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res 2007; 67: 9518-9527 [PMID: 17909062 DOI: 10.1158/0008-5472.CAN-07-0175]
7. Fukunaga A, Miyamoto M, Cho Y, Murakami S, Kawarada Y, Oshikiri T, Kato K, Kurokawa T, Suzuoki M, Nakakubo Y, Hiraoka K, Itoh T, Morikawa T, Okushiba S, Kondo S, Katoh H. CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma. Pancreas 2004; 28: e26-e31 [PMID: 14707745 DOI: 10.1097/00006676-200401000-00023]
8. Burnet FM. Immunological surveillance. Oxford: Pergamon Press, 1970
9. Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ. Natural innate and adaptive immunity to cancer. Annu Rev Immunol 2011; 29: 235-271 [PMID: 21219185 DOI: 10.1146/annurev-immunol-031210-101324]
10. Dunn GP, Bruce AT, Ikeda H, Old LJ, Schreiber RD. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol 2002; 3: 991-998 [PMID: 12407406 DOI: 10.1038/ni1102-991]
11. Dunn GP, Old LJ, Schreiber RD. The three Es of cancer immunoediting. Annu Rev Immunol 2004; 22: 329-360 [PMID: 15032581 DOI: 10.1146/annurev.immunol.22.012703.104803]
12. Cassatella MA. Neutrophil-derived proteins: selling cytokines by the pound. Adv Immunol 1999; 73: 369-509 [PMID: 10399011]
13. Hao NB, Lü MH, Fan YH, Cao YL, Zhang ZR, Yang SM. Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol 2012; 2012: 948098 [PMID: 22778768 DOI: 10.1155/2012/948098]
14. Huber S, Hoffmann R, Muskens F, Voehringer D. Alternatively activated macrophages inhibit T-cell proliferation by Stat6-dependent expression of PD-L2. Blood 2010; 116: 3311-3320 [PMID: 20625006 DOI: 10.1182/blood-2010-02-271981]
15. Gabrilovich DI, Velders MP, Sotomayor EM, Kast WM. Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells. J Immunol 2001; 166: 5398-5406 [PMID: 11313376]
16. Lin EY, Li JF, Gnatovskiy L, Deng Y, Zhu L, Grzesik DA, Qian H, Xue XN, Pollard JW. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 2006; 66: 11238-11246 [PMID: 17114237 DOI: 10.1158/0008-5472.CAN-06-1278]
17. Qian B, Deng Y, Im JH, Muschel RJ, Zou Y, Li J, Lang RA, Pollard JW. A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS One 2009; 4: e6562 [PMID: 19668347 DOI: 10.1371/journal.pone.0006562]
18. Saio M, Radoja S, Marino M, Frey AB. Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide. J Immunol 2001; 167: 5583-5593 [PMID: 11698429]
19. Rodriguez PC, Quiceno DG, Zabaleta J, Ortiz B, Zea AH, Piazuelo MB, Delgado A, Correa P, Brayer J, Sotomayor EM, Antonia S, Ochoa JB, Ochoa AC. Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res 2004; 64: 5839-5849 [PMID: 15313928 DOI: 10.1158/0008-5472.CAN-04-0465]
20. Rodriguez PC, Quiceno DG, Ochoa AC. L-arginine availability regulates T-lymphocyte cell-cycle progression. Blood 2007; 109: 1568-1573 [PMID: 17023580 DOI: blood-2006-06-031856]
21. Munder M, Choi BS, Rogers M, Kropf P. L-arginine deprivation impairs Leishmania major-specific T-cell responses. Eur J Immunol 2009; 39: 2161-2172 [PMID: 19637195 DOI: 10.1002/eji.200839041]
22. Kusmartsev S, Nefedova Y, Yoder D, Gabrilovich DI. Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J Immunol 2004; 172: 989-999 [PMID: 14707072]
23. Nagaraj S, Gabrilovich DI. Myeloid-derived suppressor cells. Adv Exp Med Biol 2007; 601: 213-223 [PMID: 17713008]
24. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9: 162-174 [PMID: 19197294 DOI: 10.1038/nri2506]
25. Bronte V, Zanovello P. Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol 2005; 5: 641-654 [PMID: 16056256 DOI: 10.1038/nri1668]
26. Huang B, Pan PY, Li Q, Sato AI, Levy DE, Bromberg J, Divino CM, Chen SH. Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res 2006; 66: 1123-1131 [PMID: 16424049 DOI: 10.1158/0008-5472.CAN-05-1299]
27. Srivastava MK, Sinha P, Clements VK, Rodriguez P, Ostrand-Rosenberg S. Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res 2010; 70: 68-77 [PMID: 20028852 DOI: 10.1158/0008-5472.CAN-09-2587]
28. Smyth MJ, Hayakawa Y, Takeda K, Yagita H. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2002; 2: 850-861 [PMID: 12415255 DOI: 10.1038/nrc928]
29. Clark GJ, Angel N, Kato M, López JA, MacDonald K, Vuckovic S, Hart DN. The role of dendritic cells in the innate immune system. Microbes Infect 2000; 2: 257-272 [PMID: 10758402 DOI: 10.1016/S1286-4579(00)00302-6]
30. Janeway C. Immunobiology: the immune system in health and disease. 6th ed. New York: Garland Science, 2005
31. Thornton AM, Shevach EM. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998; 188: 287-296 [PMID: 9670041]
32. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson J. Molecular Biology of the Cell. 3 rd ed. New York, NY: Garland Publishing Inc., 1994
33. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-867 [PMID: 12490959]
34. Nakamura T, Takeuchi T, Tando Y. Pancreatic dysfunction and treatment options. Pancreas 1998; 16: 329-336 [PMID: 9548675]
35. Russo MW, Wei JT, Thiny MT, Gangarosa LM, Brown A, Ringel Y, Shaheen NJ, Sandler RS. Digestive and liver diseases statistics, 2004. Gastroenterology 2004; 126: 1448-1453 [PMID: 15131804 DOI: 10.1053/j.gastro.2004.01.025]
36. Frossard JL, Steer ML, Pastor CM. Acute pancreatitis. Lancet 2008; 371: 143-152 [PMID: 18191686 DOI: 10.1016/S0140-6736(08)60107-5]
37. Klöppel G, Dreyer T, Willemer S, Kern HF, Adler G. Human acute pancreatitis: its pathogenesis in the light of immunocytochemical and ultrastructural findings in acinar cells. Virchows Arch A Pathol Anat Histopathol 1986; 409: 791-803 [PMID: 3094241]
38. Vidarsdottir H, Möller PH, Vidarsdottir H, Thorarinsdottir H, Björnsson ES. Acute pancreatitis: a prospective study on incidence, etiology, and outcome. Eur J Gastroenterol Hepatol 2013; 25: 1068-1075 [PMID: 23839162 DOI: 10.1097/MEG.0b013e3283640fc8]
39. Takuma K, Kamisawa T, Hara S, Tabata T, Kuruma S, Chiba K, Kuwata G, Fujiwara T, Egashira H, Koizumi K, Fujiwara J, Arakawa T, Momma K, Igarashi Y. Etiology of recurrent acute pancreatitis, with special emphasis on pancreaticobiliary malformation. Adv Med Sci 2012; 57: 244-250 [PMID: 23183766 DOI: 10.2478/v10039-012-0041-7]
40. Lowenfels AB, Maisonneuve P, Sullivan T. The changing character of acute pancreatitis: epidemiology, etiology, and prognosis. Curr Gastroenterol Rep 2009; 11: 97-103 [PMID: 19281696]
41. Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology 2013; 144: 1252-1261 [PMID: 23622135 DOI: 10.1053/j.gastro.2013.01.068]
42. Appelros S, Borgström A. Incidence, aetiology and mortality rate of acute pancreatitis over 10 years in a defined urban population in Sweden. Br J Surg 1999; 86: 465-470 [PMID: 10215815 DOI: 10.1046/j.1365-2168.1999.01049.x]
43. Renner IG, Savage WT, Pantoja JL, Renner VJ. Death due to acute pancreatitis. A retrospective analysis of 405 autopsy cases. Dig Dis Sci 1985; 30: 1005-1018 [PMID: 3896700]
44. Beger HG, Bittner R, Block S, Büchler M. Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology 1986; 91: 433-438 [PMID: 3522342]
45. Büchler MW, Gloor B, Müller CA, Friess H, Seiler CA, Uhl W. Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg 2000; 232: 619-626 [PMID: 11066131]
46. Makhija R, Kingsnorth AN. Cytokine storm in acute pancreatitis. J Hepatobiliary Pancreat Surg 2002; 9: 401-410 [PMID: 12483260 DOI: 10.1007/s005340200049]
47. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, Dimagno EP, Andrén-Sandberg A, Domellöf L. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 1993; 328: 1433-1437 [PMID: 8479461 DOI: 10.1056/NEJM199305203282001]
48. Malka D, Hammel P, Maire F, Rufat P, Madeira I, Pessione F, Lévy P, Ruszniewski P. Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut 2002; 51: 849-852 [PMID: 12427788]
49. Pinho AV, Chantrill L, Rooman I. Chronic pancreatitis: a path to pancreatic cancer. Cancer Lett 2014; 345: 203-209 [PMID: 23981573 DOI: 10.1016/j.canlet.2013.08.015]
50. Freedman SD. Clinical manifestations and diagnosis of chronic pancreatitis in adults. In: Basow DS, editor. Waltham, MA: UpToDate, 2013
51. Büchler MW, Martignoni ME, Friess H, Malfertheiner P. A proposal for a new clinical classification of chronic pancreatitis. BMC Gastroenterol 2009; 9: 93 [PMID: 20003450 DOI: 10.1186/1471-230X-9-93]
52. Etemad B, Whitcomb DC. Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology 2001; 120: 682-707 [PMID: 11179244 DOI: 10.1053/gast.2001.22586]
53. Mergener K, Baillie J. Chronic pancreatitis. Lancet 1997; 350: 1379-1385 [PMID: 9365465 DOI: 10.1016/S0140-6736(97)07332-7]
54. Klöppel G, Maillet B. Pathology of acute and chronic pancreatitis. Pancreas 1993; 8: 659-670 [PMID: 8255882]
55. Hirota M, Kuwata K, Ohmuraya M, Ogawa M. From acute to chronic pancreatitis: the role of mutations in the pancreatic secretory trypsin inhibitor gene. JOP 2003; 4: 83-88 [PMID: 12629264]
56. Zhou ZG, Chen YD, Sun W, Chen Z. Pancreatic microcirculatory impairment in experimental acute pancreatitis in rats. World J Gastroenterol 2002; 8: 933-936 [PMID: 12378645]
57. Rinderknecht H. Fatal pancreatitis, a consequence of excessive leukocyte stimulation? Int J Pancreatol 1988; 3: 105-112 [PMID: 2834471 DOI: 10.1007/BF02798921]
58. Wang GJ, Gao CF, Wei D, Wang C, Ding SQ. Acute pancreatitis: etiology and common pathogenesis. World J Gastroenterol 2009; 15: 1427-1430 [PMID: 19322914]
59. Frick TW. The role of calcium in acute pancreatitis. Surgery 2012; 152: S157-S163 [PMID: 22906890 DOI: 10.1016/j.surg.2012.05.013]
60. Gerasimenko OV, Gerasimenko JV. Mitochondrial function and malfunction in the pathophysiology of pancreatitis. Pflugers Arch 2012; 464: 89-99 [PMID: 22653502 DOI: 10.1007/s00424-012-1117-8]
61. Cuthbertson CM, Christophi C. Disturbances of the microcirculation in acute pancreatitis. Br J Surg 2006; 93: 518-530 [PMID: 16607683 DOI: 10.1002/bjs.5316]
62. Viedma JA, Pérez-Mateo M, Agulló J, Domínguez JE, Carballo F. Inflammatory response in the early prediction of severity in human acute pancreatitis. Gut 1994; 35: 822-827 [PMID: 7517379]
63. Banks RE, Evans SW, Alexander D, McMahon MJ, Whicher JT. Is fatal pancreatitis a consequence of excessive leukocyte stimulation? The role of tumor necrosis factor alpha. Cytokine 1991; 3: 12-16 [PMID: 1883952 DOI: 10.1016/1043-4666(91)90004-W]
64. Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol 2004; 172: 2731-2738 [PMID: 14978070]
65. Novovic S, Andersen AM, Nord M, Astrand M, Ottosson T, Jørgensen LN, Hansen MB. Activity of neutrophil elastase reflects the progression of acute pancreatitis. Scand J Clin Lab Invest 2013; 73: 485-493 [PMID: 23819644 DOI: 10.3109/00365513.2013.807935]
66. Uhl W, Büchler M, Malfertheiner P, Martini M, Beger HG. PMN-elastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas 1991; 6: 253-259 [PMID: 1713669]
67. Widdison AL, Cunningham S. Immune function early in acute pancreatitis. Br J Surg 1996; 83: 633-636 [PMID: 8689205]
68. Regnér S, Manjer J, Appelros S, Hjalmarsson C, Sadic J, Borgström A. Protease activation, pancreatic leakage, and inflammation in acute pancreatitis: differences between mild and severe cases and changes over the first three days. Pancreatology 2008; 8: 600-607 [PMID: 18849642]
69. Kylänpää ML, Repo H, Puolakkainen PA. Inflammation and immunosuppression in severe acute pancreatitis. World J Gastroenterol 2010; 16: 2867-2872 [PMID: 20556831]
70. McKay CJ, Evans S, Sinclair M, Carter CR, Imrie CW. High early mortality rate from acute pancreatitis in Scotland, 1984-1995. Br J Surg 1999; 86: 1302-1305 [PMID: 10540138 DOI: 10.1046/j.1365-2168.1999.01246.x]
71. Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 1996; 24: 1125-1128 [PMID: 8674323]
72. Pezzilli R, Billi P, Beltrandi E, Maldini M, Mancini R, Morselli Labate AM, Miglioli M. Circulating lymphocyte subsets in human acute pancreatitis. Pancreas 1995; 11: 95-100 [PMID: 7667248]
73. Dabrowski A, Osada J, Dabrowska MI, Wereszczynska-Siemiatkowska U. Monocyte subsets and natural killer cells in acute pancreatitis. Pancreatology 2008; 8: 126-134 [PMID: 18382098 DOI: 10.1159/000123605]
74. Pezzilli R, Maldini M, Morselli-Labate AM, Barakat B, Romboli E, Beltrandi E, Migliori M, Tomassetti P, Corinaldesi R. Early activation of peripheral lymphocytes in human acute pancreatitis. J Clin Gastroenterol 2003; 36: 360-363 [PMID: 12642746]
75. Ueda T, Takeyama Y, Yasuda T, Shinzeki M, Sawa H, Nakajima T, Ajiki T, Fujino Y, Suzuki Y, Kuroda Y. Immunosuppression in patients with severe acute pancreatitis. J Gastroenterol 2006; 41: 779-784 [PMID: 16988767 DOI: 10.1007/s00535-006-1852-8]
76. Takeyama Y, Takas K, Ueda T, Hori Y, Goshima M, Kuroda Y. Peripheral lymphocyte reduction in severe acute pancreatitis is caused by apoptotic cell death. J Gastrointest Surg 2000; 4: 379-387 [PMID: 11058856 DOI: 10.1016/S1091-255X(00)80016-5]
77. Kylänpää-Bäck ML, Takala A, Kemppainen E, Puolakkainen P, Kautiainen H, Jansson SE, Haapiainen R, Repo H. Cellular markers of systemic inflammation and immune suppression in patients with organ failure due to severe acute pancreatitis. Scand J Gastroenterol 2001; 36: 1100-1107 [PMID: 11589386]
78. Richter A, Nebe T, Wendl K, Schuster K, Klaebisch G, Quintel M, Lorenz D, Post S, Trede M. HLA-DR expression in acute pancreatitis. Eur J Surg 1999; 165: 947-951 [PMID: 10574102 DOI: 10.1080/110241599750008053]
79. Yamaguchi H, Kimura T, Mimura K, Nawata H. Activation of proteases in cerulein-induced pancreatitis. Pancreas 1989; 4: 565-571 [PMID: 2478999]
80. Lampel M, Kern HF. Acute interstitial pancreatitis in the rat induced by excessive doses of a pancreatic secretagogue. Virchows Arch A Pathol Anat Histol 1977; 373: 97-117 [PMID: 139754]
81. Song MH, Kim MH, Lee SK, Seo DW. The clinical usefulness of secretin-enhanced magnetic resonance pancreatography in patients with pancreas divisum and idiopathic acute pancreatitis. Gastrointest Endosc 2002; 55: 454-455 [PMID: 11868034 DOI: 10.1067/mge.2002.121601]
82. Walker NI. Ultrastructure of the rat pancreas after experimental duct ligation. I. The role of apoptosis and intraepithelial macrophages in acinar cell deletion. Am J Pathol 1987; 126: 439-451 [PMID: 3826300]
83. Mizunuma T, Kawamura S, Kishino Y. Effects of injecting excess arginine on rat pancreas. J Nutr 1984; 114: 467-471 [PMID: 6199486]
84. Lombardi B, Estes LW, Longnecker DS. Acute hemorrhagic pancreatitis (massive necrosis) with fat necrosis induced in mice by DL-ethionine fed with a choline-deficient diet. Am J Pathol 1975; 79: 465-480 [PMID: 1094837]
85. Nutrition classics from The Journal of Biological Chemistry, 131: 567-577, 1937.
86. Choline metabolism. I. The occurrence and prevention of hemorrhagic degeneration in young rats on a low choline diet. By Wendell H. Griffith and Nelson J. Wade. Nutr Rev 1974; 32: 112-114 [PMID: 4597260]
87. THAL A, BRACKNEY E. Acute hemorrhagic pancreatic necrosis produced by local Shwartzman reaction: experimental study on pancreatitis. J Am Med Assoc 1954; 155: 569-574 [PMID: 13162758]
88. Meyerholz DK, Samuel I. Morphologic characterization of early ligation-induced acute pancreatitis in rats. Am J Surg 2007; 194: 652-658 [PMID: 17936429 DOI: 10.1016/j.amjsurg.2007.07.014]
89. Pastor CM, Vonlaufen A, Georgi F, Hadengue A, Morel P, Frossard JL. Neutrophil depletion - but not prevention of Kupffer cell activation - decreases the severity of ceruleininduced acute pancreatitis. World J Gastroenterol 2006; 12: 1219-1224 [PMID: 16534874]
90. Sandoval D, Gukovskaya A, Reavey P, Gukovsky S, Sisk A, Braquet P, Pandol SJ, Poucell-Hatton S. The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis. Gastroenterology 1996; 111: 1081-1091 [PMID: 8831604 DOI: 10.1016/S0016-5085(96)70077-X]
91. Folch E, Prats N, Hotter G, López S, Gelpi E, Roselló-Catafau J, Closa D. P-selectin expression and Kupffer cell activation in rat acute pancreatitis. Dig Dis Sci 2000; 45: 1535-1544 [PMID: 11007102]
92. Awla D, Abdulla A, Zhang S, Roller J, Menger MD, Regnér S, Thorlacius H. Lymphocyte function antigen-1 regulates neutrophil recruitment and tissue damage in acute pancreatitis. Br J Pharmacol 2011; 163: 413-423 [PMID: 21244370 DOI: 10.1111/j.1476-5381.2011.01225.x]
93. Kyriakides C, Jasleen J, Wang Y, Moore FD, Ashley SW, Hechtman HB. Neutrophils, not complement, mediate the mortality of experimental hemorrhagic pancreatitis. Pancreas 2001; 22: 40-46 [PMID: 11138969]
94. Pastor CM, Rubbia-Brandt L, Hadengue A, Jordan M, Morel P, Frossard JL. Role of macrophage inflammatory peptide-2 in cerulein-induced acute pancreatitis and pancreatitis-associated lung injury. Lab Invest 2003; 83: 471-478 [PMID: 12695550]
95. Lopez-Font I, Gea-Sorlí S, de-Madaria E, Gutiérrez LM, Pérez-Mateo M, Closa D. Pancreatic and pulmonary mast cells activation during experimental acute pancreatitis. World J Gastroenterol 2010; 16: 3411-3417 [PMID: 20632444]
96. Bedrosian AS, Nguyen AH, Hackman M, Connolly MK, Malhotra A, Ibrahim J, Cieza-Rubio NE, Henning JR, Barilla R, Rehman A, Pachter HL, Medina-Zea MV, Cohen SM, Frey AB, Acehan D, Miller G. Dendritic cells promote pancreatic viability in mice with acute pancreatitis. Gastroenterology 2011; 141: 1915-26.e1-14 [PMID: 21801698 DOI: 10.1053/j.gastro.2011.07.033]
97. Curley P, Nestor M, Collins K, Saporoschetz I, Mendez M, Mannick JA, Rodrick ML. Decreased interleukin-2 production in murine acute pancreatitis: potential for immunomodulation. Gastroenterology 1996; 110: 583-588 [PMID: 8566607 DOI: 10.1053/gast.1996.v110.pm8566607]
98. Demols A, Le Moine O, Desalle F, Quertinmont E, Van Laethem JL, Devière J. CD4(+)T cells play an important role in acute experimental pancreatitis in mice. Gastroenterology 2000; 118: 582-590 [PMID: 10702210 DOI: 10.1016/S0016-5085(00)70265-4]
99. Dios ID. Inflammatory role of the acinar cells during acute pancreatitis. World J Gastrointest Pharmacol Ther 2010; 1: 15-20 [PMID: 21577290 DOI: 10.4292/wjgpt.v1.i1.15]
100. Norman JG, Fink GW, Franz MG. Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg 1995; 130: 966-970 [PMID: 7661681]
101. Norman J, Franz M, Riker A, Fabri P, Gower W. Rapid Elevation of Systemic Cytokines During Acute Pancreatitis and Their Origination Within the Pancreas. Surgical Forum 1994; 45: 148-150
102. Xie MJ, Motoo Y, Su SB, Mouri H, Sawabu N. Induction of chemokines in rat pancreatic acinar cell injury. Pancreas 2002; 24: 198-204 [PMID: 11854626]
103. Motoo Y, Xie MJ, Mouri H, Sawabu N. Expression of interleukin-8 in human obstructive pancreatitis. JOP 2004; 5: 138-144 [PMID: 15138335]
104. Kempuraj D, Twait EC, Williard DE, Yuan Z, Meyerholz DK, Samuel I. The novel cytokine interleukin-33 activates acinar cell proinflammatory pathways and induces acute pancreatic inflammation in mice. PLoS One 2013; 8: e56866 [PMID: 23418608 DOI: 10.1371/journal.pone.0056866]
105. Yu JH, Kim KH, Kim H. Suppression of IL-1beta expression by the Jak 2 inhibitor AG490 in cerulein-stimulated pancreatic acinar cells. Biochem Pharmacol 2006; 72: 1555-1562 [PMID: 16934228]
106. Blinman TA, Gukovsky I, Mouria M, Zaninovic V, Livingston E, Pandol SJ, Gukovskaya AS. Activation of pancreatic acinar cells on isolation from tissue: cytokine upregulation via p38 MAP kinase. Am J Physiol Cell Physiol 2000; 279: C1993-C2003 [PMID: 11078716]
107. Bhatia M. Inflammatory response on the pancreatic acinar cell injury. Scand J Surg 2005; 94: 97-102 [PMID: 16111089]
108. Granger J, Remick D. Acute pancreatitis: models, markers, and mediators. Shock 2005; 24 Suppl 1: 45-51 [PMID: 16374372 DOI: 10.1016/j.bcp.2006.07.008]
109. Bhatia M, Brady M, Shokuhi S, Christmas S, Neoptolemos JP, Slavin J. Inflammatory mediators in acute pancreatitis. J Pathol 2000; 190: 117-125 [PMID: 10657008]
110. Norman JG, Fink GW, Denham W, Yang J, Carter G, Sexton C, Falkner J, Gower WR, Franz MG. Tissue-specific cytokine production during experimental acute pancreatitis. A probable mechanism for distant organ dysfunction. Dig Dis Sci 1997; 42: 1783-1788 [PMID: 9286248]
111. Viedma JA, Pérez-Mateo M, Domínguez JE, Carballo F. Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A. Gut 1992; 33: 1264-1267 [PMID: 1427382]
112. Heath DI, Cruickshank A, Gudgeon M, Jehanli A, Shenkin A, Imrie CW. Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis. Gut 1993; 34: 41-45 [PMID: 7679365]
113. Pezzilli R, Miniero R, Cappelletti O, Barakat B. Behavior of serum interleukin 12 in human acute pancreatitis. Pancreas 1999; 18: 247-251 [PMID: 10206482]
114. Matull WR, Pereira SP, O'Donohue JW. Biochemical markers of acute pancreatitis. J Clin Pathol 2006; 59: 340-344 [PMID: 16567468 DOI: 10.1136/jcp.2002.002923]
115. Grewal HP, Kotb M, el Din AM, Ohman M, Salem A, Gaber L, Gaber AO. Induction of tumor necrosis factor in severe acute pancreatitis and its subsequent reduction after hepatic passage. Surgery 1994; 115: 213-221 [PMID: 8310410]
116. Sorimachi K, Akimoto K, Hattori Y, Ieiri T, Niwa A. Secretion of TNF-alpha, IL-8 and nitric oxide by macrophages activated with polyanions, and involvement of interferongamma in the regulation of cytokine secretion. Cytokine 1999; 11: 571-578 [PMID: 10433803 DOI: 10.1006/cyto.1998.0472]
117. Gross V, Andreesen R, Leser HG, Ceska M, Liehl E, Lausen M, Farthmann EH, Schölmerich J. Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest 1992; 22: 200-203 [PMID: 1582445]
118. Baggiolini M, Walz A, Kunkel SL. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989; 84: 1045-1049 [PMID: 2677047 DOI: 10.1172/JCI114265]
119. Yamada T, Hashimoto T, Sogawa M, Kobayashi S, Kaneda K, Nakamura S, Kuno A, Sano H, Ando T, Kobayashi S, Aoki S, Nakazawa T, Ohara H, Nomura T, Joh T, Itoh M. Role of T cells in development of chronic pancreatitis in male Wistar Bonn/Kobori rats: effects of tacrolimus. Am J Physiol Gastrointest Liver Physiol 2001; 281: G1397-G1404 [PMID: 11705744]
120. Emmrich J, Weber I, Nausch M, Sparmann G, Koch K, Seyfarth M, Löhr M, Liebe S. Immunohistochemical characterization of the pancreatic cellular infiltrate in normal pancreas, chronic pancreatitis and pancreatic carcinoma. Digestion 1998; 59: 192-198 [PMID: 9643678 DOI: 10.1159/000007488]
121. Demir IE, Schorn S, Schremmer-Danninger E, Wang K, Kehl T, Giese NA, Algül H, Friess H, Ceyhan GO. Perineural mast cells are specifically enriched in pancreatic neuritis and neuropathic pain in pancreatic cancer and chronic pancreatitis. PLoS One 2013; 8: e60529 [PMID: 23555989 DOI: 10.1371/journal.pone.0060529]
122. Grundsten M, Liu GZ, Permert J, Hjelmstrom P, Tsai JA. Increased central memory T cells in patients with chronic pancreatitis. Pancreatology 2005; 5: 177-182 [PMID: 15849488 DOI: 10.1159/000085269]
123. Ebert MP, Ademmer K, Müller-Ostermeyer F, Friess H, Büchler MW, Schubert W, Malfertheiner P. CD8+CD103+ T cells analogous to intestinal intraepithelial lymphocytes infiltrate the pancreas in chronic pancreatitis. Am J Gastroenterol 1998; 93: 2141-2147 [PMID: 9820387 DOI: 10.1111/j.1572-0241.1998.00610.x]
124. Bhatnagar A, Wig JD, Majumdar S. Immunological findings in acute and chronic pancreatitis. ANZ J Surg 2003; 73: 59-64 [PMID: 12534743]
125. Ockenga J, Jacobs R, Kemper A, Benschop RJ, Schmidt RE, Manns MP. Lymphocyte subsets and cellular immunity in patients with chronic pancreatitis. Digestion 2000; 62: 14-21 [PMID: 10899720]
126. Hoogerwerf WA, Gondesen K, Xiao SY, Winston JH, Willis WD, Pasricha PJ. The role of mast cells in the pathogenesis of pain in chronic pancreatitis. BMC Gastroenterol 2005; 5: 8 [PMID: 15745445 DOI: 10.1186/1471-230X-5-8]
127. Esposito I, Friess H, Kappeler A, Shrikhande S, Kleeff J, Ramesh H, Zimmermann A, Büchler MW. Mast cell distribution and activation in chronic pancreatitis. Hum Pathol 2001; 32: 1174-1183 [PMID: 11727255 DOI: 10.1053/hupa.2001.28947]
128. Schmitz-Winnenthal H, Pietsch DH, Schimmack S, Bonertz A, Udonta F, Ge Y, Galindo L, Specht S, Volk C, Zgraggen K, Koch M, Büchler MW, Weitz J, Beckhove P. Chronic pancreatitis is associated with disease-specific regulatory T-cell responses. Gastroenterology 2010; 138: 1178-1188 [PMID: 19931255 DOI: 10.1053/j.gastro.2009.11.011]
129. Aghdassi AA, Mayerle J, Christochowitz S, Weiss FU, Sendler M, Lerch MM. Animal models for investigating chronic pancreatitis. Fibrogenesis Tissue Repair 2011; 4: 26 [PMID: 22133269 DOI: 10.1186/1755-1536-4-26]
130. Bai H, Chen X, Zhang L, Dou X. The effect of sulindac, a non-steroidal anti-inflammatory drug, attenuates inflammation and fibrosis in a mouse model of chronic pancreatitis. BMC Gastroenterol 2012; 12: 115 [PMID: 22920325 DOI: 10.1186/1471-230X-12-115]
131. van Westerloo DJ, Florquin S, de Boer AM, Daalhuisen J, de Vos AF, Bruno MJ, van der Poll T. Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice. Am J Pathol 2005; 166: 721-728 [PMID: 15743784 DOI: 10.1016/S0002-9440(10)62293-6]
132. Farrow B, Evers BM. Inflammation and the development of pancreatic cancer. Surg Oncol 2002; 10: 153-169 [PMID: 12020670 DOI: 10.1016/S0960-7404(02)00015-4]
133. Pérez-Mancera PA, Guerra C, Barbacid M, Tuveson DA. What we have learned about pancreatic cancer from mouse models. Gastroenterology 2012; 142: 1079-1092 [PMID: 22406637 DOI: 10.1053/j.gastro.2012.03.002]
134. Hruban RH, van Mansfeld AD, Offerhaus GJ, van Weering DH, Allison DC, Goodman SN, Kensler TW, Bose KK, Cameron JL, Bos JL. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993; 143: 545-554 [PMID: 8342602]
135. Löhr M, Klöppel G, Maisonneuve P, Lowenfels AB, Lüttges J. Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis. Neoplasia 2005; 7: 17-23 [PMID: 15720814 DOI: 10.1593/neo.04445]
136. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, Ross S, Conrads TP, Veenstra TD, Hitt BA, Kawaguchi Y, Johann D, Liotta LA, Crawford HC, Putt ME, Jacks T, Wright CV, Hruban RH, Lowy AM, Tuveson DA. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003; 4: 437-450 [PMID: 14706336]
137. Fogar P, Sperti C, Basso D, Sanzari MC, Greco E, Davoli C, Navaglia F, Zambon CF, Pasquali C, Venza E, Pedrazzoli S, Plebani M. Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas 2006; 32: 22-28 [PMID: 16340740]
138. Emmrich J, Sparmann G, Hopt U, Löhr M, Liebe S. Typing of leukocytes in pancreatic tissue surrounding human pancreatic carcinoma. Ann N Y Acad Sci 1999; 880: 171-174 [PMID: 10415861]
139. Ademmer K, Ebert M, Müller-Ostermeyer F, Friess H, Büchler MW, Schubert W, Malfertheiner P. Effector T lymphocyte subsets in human pancreatic cancer: detection of CD8+CD18+ cells and CD8+CD103+ cells by multi-epitope imaging. Clin Exp Immunol 1998; 112: 21-26 [PMID: 9566785]
140. Ryschich E, Nötzel T, Hinz U, Autschbach F, Ferguson J, Simon I, Weitz J, Fröhlich B, Klar E, Büchler MW, Schmidt J. Control of T-cell-mediated immune response by HLA class I in human pancreatic carcinoma. Clin Cancer Res 2005; 11: 498-504 [PMID: 15701833]
141. Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, Doherty G, Drebin JA, Strasberg SM, Eberlein TJ, Goedegebuure PS, Linehan DC. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002; 169: 2756-2761 [PMID: 12193750]
142. Hiraoka N, Onozato K, Kosuge T, Hirohashi S. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 2006; 12: 5423-5434 [PMID: 17000676 DOI: 10.1158/1078-0432.CCR-06-0369]
143. Ikemoto T, Shimada M, Komatsu M, Yamada S, Saito Y, Mori H, Morine Y, Imura S, Bando Y, Utsunomiya T. Indoleamine 2,3-dioxygenase affects the aggressiveness of intraductal papillary mucinous neoplasms through Foxp3+CD4+CD25+ T cells in peripheral blood. Pancreas 2013; 42: 130-134 [PMID: 22722263 DOI: 10.1097/MPA.0b013e3182575e4a]
144. Ikemoto T, Yamaguchi T, Morine Y, Imura S, Soejima Y, Fujii M, Maekawa Y, Yasutomo K, Shimada M. Clinical roles of increased populations of Foxp3+CD4+ T cells in peripheral blood from advanced pancreatic cancer patients. Pancreas 2006; 33: 386-390 [PMID: 17079944 DOI: 10.1097/01.mpa.0000240275.68279.13]
145. Linehan DC, Goedegebuure PS. CD25+ CD4+ regulatory T-cells in cancer. Immunol Res 2005; 32: 155-168 [PMID: 16106066]
146. Tan MC, Goedegebuure PS, Belt BA, Flaherty B, Sankpal N, Gillanders WE, Eberlein TJ, Hsieh CS, Linehan DC. Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. J Immunol 2009; 182: 1746-1755 [PMID: 19155524 DOI: 10.4049/jimmunol.182.3.1746]
147. Porembka MR, Mitchem JB, Belt BA, Hsieh CS, Lee HM, Herndon J, Gillanders WE, Linehan DC, Goedegebuure P. Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth. Cancer Immunol Immunother 2012; 61: 1373-1385 [PMID: 22215137 DOI: 10.1007/s00262-011-1178-0]
148. Gabitass RF, Annels NE, Stocken DD, Pandha HA, Middleton GW. Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13. Cancer Immunol Immunother 2011; 60: 1419-1430 [PMID: 21644036 DOI: 10.1007/s00262-011-1028-0]
149. Basso D, Fogar P, Falconi M, Fadi E, Sperti C, Frasson C, Greco E, Tamburrino D, Teolato S, Moz S, Bozzato D, Pelloso M, Padoan A, De Franchis G, Gnatta E, Facco M, Zambon CF, Navaglia F, Pasquali C, Basso G, Semenzato G, Pedrazzoli S, Pederzoli P, Plebani M. Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study. PLoS One 2013; 8: e54824 [PMID: 23359812 DOI: 10.1371/journal.pone.0054824]
150. Diaz-Montero CM, Salem ML, Nishimura MI, Garrett-Mayer E, Cole DJ, Montero AJ. Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother 2009; 58: 49-59 [PMID: 18446337 DOI: 10.1007/s00262-008-0523-4]
151. Bayne LJ, Beatty GL, Jhala N, Clark CE, Rhim AD, Stanger BZ, Vonderheide RH. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 2012; 21: 822-835 [PMID: 22698406 DOI: 10.1016/j.ccr.2012.04.025]
152. Zhao F, Obermann S, von Wasielewski R, Haile L, Manns MP, Korangy F, Greten TF. Increase in frequency of myeloid-derived suppressor cells in mice with spontaneous pancreatic carcinoma. Immunology 2009; 128: 141-149 [PMID: 19689743 DOI: 10.1111/j.1365-2567.2009.03105.x]
153. Esposito I, Menicagli M, Funel N, Bergmann F, Boggi U, Mosca F, Bevilacqua G, Campani D. Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J Clin Pathol 2004; 57: 630-636 [PMID: 15166270]
154. Tsuzuki Y, Mouta Carreira C, Bockhorn M, Xu L, Jain RK, Fukumura D. Pancreas microenvironment promotes VEGF expression and tumor growth: novel window models for pancreatic tumor angiogenesis and microcirculation. Lab Invest 2001; 81: 1439-1451 [PMID: 11598156]
155. Yamazaki K, Nagao T, Yamaguchi T, Saisho H, Kondo Y. Expression of basic fibroblast growth factor (FGF-2)-associated with tumour proliferation in human pancreatic carcinoma. Virchows Arch 1997; 431: 95-101 [PMID: 9293890]
156. Strouch MJ, Cheon EC, Salabat MR, Krantz SB, Gounaris E, Melstrom LG, Dangi-Garimella S, Wang E, Munshi HG, Khazaie K, Bentrem DJ. Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression. Clin Cancer Res 2010; 16: 2257-2265 [PMID: 20371681 DOI: 10.1158/1078-0432.CCR-09-1230]
157. Cai SW, Yang SZ, Gao J, Pan K, Chen JY, Wang YL, Wei LX, Dong JH. Prognostic significance of mast cell count following curative resection for pancreatic ductal adenocarcinoma. Surgery 2011; 149: 576-584 [PMID: 21167541 DOI: 10.1016/j.surg.2010.10.009]
158. Ma Y, Hwang RF, Logsdon CD, Ullrich SE. Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer. Cancer Res 2013; 73: 3927-3937 [PMID: 23633481 DOI: 10.1158/0008-5472.CAN-12-4479]
159. Chang DZ, Ma Y, Ji B, Wang H, Deng D, Liu Y, Abbruzzese JL, Liu YJ, Logsdon CD, Hwu P. Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma. Clin Cancer Res 2011; 17: 7015-7023 [PMID: 21976550 DOI: 10.1158/1078-0432.CCR-11-0607]
160. Guerra C, Schuhmacher AJ, Cañamero M, Grippo PJ, Verdaguer L, Pérez-Gallego L, Dubus P, Sandgren EP, Barbacid M. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 2007; 11: 291-302 [PMID: 17349585]
161. Koizumi M, Hiasa Y, Kumagi T, Yamanishi H, Azemoto N, Kobata T, Matsuura B, Abe M, Onji M. Increased B cell-activating factor promotes tumor invasion and metastasis in human pancreatic cancer. PLoS One 2013; 8: e71367 [PMID: 23940742 DOI: 10.1371/journal.pone.0071367]
162. Gaida MM, Steffen TG, Günther F, Tschaharganeh DF, Felix K, Bergmann F, Schirmacher P, Hänsch GM. Polymorphonuclear neutrophils promote dyshesion of tumor cells and elastase-mediated degradation of E-cadherin in pancreatic tumors. Eur J Immunol 2012; 42: 3369-3380 [PMID: 23001948 DOI: 10.1002/eji.201242628]
163. Grosse-Steffen T, Giese T, Giese N, Longerich T, Schirmacher P, Hänsch GM, Gaida MM. Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma and pancreatic tumor cell lines: the role of neutrophils and neutrophil-derived elastase. Clin Dev Immunol 2012; 2012: 720768 [PMID: 23227088 DOI: 10.1155/2012/720768]
164. Bausch D, Pausch T, Krauss T, Hopt UT, Fernandez-del-Castillo C, Warshaw AL, Thayer SP, Keck T. Neutrophil granulocyte derived MMP-9 is a VEGF independent functional component of the angiogenic switch in pancreatic ductal adenocarcinoma. Angiogenesis 2011; 14: 235-243 [PMID: 21442180 DOI: 10.1007/s10456-011-9207-3]
165. Benson DD, Meng X, Fullerton DA, Moore EE, Lee JH, Ao L, Silliman CC, Barnett CC. Activation state of stromal inflammatory cells in murine metastatic pancreatic adenocarcinoma. Am J Physiol Regul Integr Comp Physiol 2012; 302: R1067-R1075 [PMID: 22422663 DOI: 10.1152/ajpregu.00320.2011]
166. Reid MD, Basturk O, Thirabanjasak D, Hruban RH, Klimstra DS, Bagci P, Altinel D, Adsay V. Tumor-infiltrating neutrophils in pancreatic neoplasia. Mod Pathol 2011; 24: 1612-1619 [PMID: 21822201 DOI: 10.1038/modpathol.2011.113]
167. Phan VT, Wu X, Cheng JH, Sheng RX, Chung AS, Zhuang G, Tran C, Song Q, Kowanetz M, Sambrone A, Tan M, Meng YG, Jackson EL, Peale FV, Junttila MR, Ferrara N. Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF-induced neutrophil recruitment. Proc Natl Acad Sci USA 2013; 110: 6079-6084 [PMID: 23530240 DOI: 10.1073/pnas.1303302110]
168. Khayyata S, Basturk O, Adsay NV. Invasive micropapillary carcinomas of the ampullo-pancreatobiliary region and their association with tumor-infiltrating neutrophils. Mod Pathol 2005; 18: 1504-1511 [PMID: 16007065 DOI: 10.1038/modpathol.3800460]
169. Bhatti I, Peacock O, Lloyd G, Larvin M, Hall RI. Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am J Surg 2010; 200: 197-203 [PMID: 20122680 DOI: 10.1016/j.amjsurg.2009.08.041]
170. Wang DS, Luo HY, Qiu MZ, Wang ZQ, Zhang DS, Wang FH, Li YH, Xu RH. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Med Oncol 2012; 29: 3092-3100 [PMID: 22476808 DOI: 10.1007/s12032-012-0226-8]
171. Almand B, Clark JI, Nikitina E, van Beynen J, English NR, Knight SC, Carbone DP, Gabrilovich DI. Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J Immunol 2001; 166: 678-689 [PMID: 11123353]
172. Nestle FO, Burg G, Fäh J, Wrone-Smith T, Nickoloff BJ. Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells. Am J Pathol 1997; 150: 641-651 [PMID: 9033277]
173. Chaux P, Favre N, Bonnotte B, Moutet M, Martin M, Martin F. Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression. A role in the immune tolerance to antigenic tumors. Adv Exp Med Biol 1997; 417: 525-528 [PMID: 9286414]
174. Kiertscher SM, Luo J, Dubinett SM, Roth MD. Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells. J Immunol 2000; 164: 1269-1276 [PMID: 10640740 DOI: 10.4049/jimmunol.164.3.1269]
175. Bellone G, Carbone A, Smirne C, Scirelli T, Buffolino A, Novarino A, Stacchini A, Bertetto O, Palestro G, Sorio C, Scarpa A, Emanuelli G, Rodeck U. Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells. J Immunol 2006; 177: 3448-3460 [PMID: 16920987 DOI: 10.4049/jimmunol.177.5.3448]
176. Allavena P, Piemonti L, Longoni D, Bernasconi S, Stoppacciaro A, Ruco L, Mantovani A. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur J Immunol 1998; 28: 359-369 [PMID: 9485215]
177. De Smedt T, Van Mechelen M, De Becker G, Urbain J, Leo O, Moser M. Effect of interleukin-10 on dendritic cell maturation and function. Eur J Immunol 1997; 27: 1229-1235 [PMID: 9174615 DOI: 10.1002/eji.1830270526]
178. Menetrier-Caux C, Thomachot MC, Alberti L, Montmain G, Blay JY. IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells. Cancer Res 2001; 61: 3096-3104 [PMID: 11306493]
179. Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, Kavanaugh D, Carbone DP. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 1996; 2: 1096-1103 [PMID: 8837607]
180. Strobl H, Knapp W. TGF-beta1 regulation of dendritic cells. Microbes Infect 1999; 1: 1283-1290 [PMID: 10611756 DOI: 10.1016/S1286-4579(99)00256-7]
181. Chomarat P, Banchereau J, Davoust J, Palucka AK. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol 2000; 1: 510-514 [PMID: 11101873 DOI: 10.1038/82763]
182. Menetrier-Caux C, Montmain G, Dieu MC, Bain C, Favrot MC, Caux C, Blay JY. Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood 1998; 92: 4778-4791 [PMID: 9845545]
183. Monti P, Leone BE, Zerbi A, Balzano G, Cainarca S, Sordi V, Pontillo M, Mercalli A, Di Carlo V, Allavena P, Piemonti L. Tumor-derived MUC1 mucins interact with differentiating monocytes and induce IL-10highIL-12low regulatory dendritic cell. J Immunol 2004; 172: 7341-7349 [PMID: 15187110]
184. Tjomsland V, Sandström P, Spa˚ngeus A, Messmer D, Emilsson J, Falkmer U, Falkmer S, Magnusson KE, Borch K, Larsson M. Pancreatic adenocarcinoma exerts systemic effects on the peripheral blood myeloid and plasmacytoid dendritic cells: an indicator of disease severity? BMC Cancer 2010; 10: 87 [PMID: 20214814 DOI: 10.1186/1471-2407-10-87]
185. Tjomsland V, Spa˚ngeus A, Sandström P, Borch K, Messmer D, Larsson M. Semi mature blood dendritic cells exist in patients with ductal pancreatic adenocarcinoma owing to inflammatory factors released from the tumor. PLoS One 2010; 5: e13441 [PMID: 20976171 DOI: 10.1371/journal.pone.0013441]
186. Takahashi K, Toyokawa H, Takai S, Satoi S, Yanagimoto H, Terakawa N, Araki H, Kwon AH, Kamiyama Y. Surgical influence of pancreatectomy on the function and count of circulating dendritic cells in patients with pancreatic cancer. Cancer Immunol Immunother 2006; 55: 775-784 [PMID: 16167144 DOI: 10.1007/s00262-005-0079-5]
187. Yanagimoto H, Takai S, Satoi S, Toyokawa H, Takahashi K, Terakawa N, Kwon AH, Kamiyama Y. Impaired function of circulating dendritic cells in patients with pancreatic cancer. Clin Immunol 2005; 114: 52-60 [PMID: 15596409 DOI: 10.1016/j.clim.2004.09.007]
188. Funa K, Nilsson B, Jacobsson G, Alm GV. Decreased natural killer cell activity and interferon production by leucocytes in patients with adenocarcinoma of the pancreas. Br J Cancer 1984; 50: 231-233 [PMID: 6466540]
189. Aparicio-Pagés MN, Verspaget HW, Peña AS, Jansen JB, Lamers CB. Natural killer cell activity in patients with neuroendocrine tumours of the gastrointestinal tract; relation with circulating gastrointestinal hormones. Neuropeptides 1991; 20: 1-7 [PMID: 1791920]
190. Fogar P, Basso D, Fadi E, Greco E, Pantano G, Padoan A, Bozzato D, Facco M, Sanzari MC, Teolato S, Zambon CF, Navaglia F, Semenzato G, Pedrazzoli S, Plebani M. Pancreatic cancer alters human CD4+ T lymphocyte function: a piece in the immune evasion puzzle. Pancreas 2011; 40: 1131-1137 [PMID: 21792088 DOI: 10.1097/MPA.0b013e31822077b8]
191. von Bernstorff W, Voss M, Freichel S, Schmid A, Vogel I, Jöhnk C, Henne-Bruns D, Kremer B, Kalthoff H. Systemic and local immunosuppression in pancreatic cancer patients. Clin Cancer Res 2001; 7: 925s-932s [PMID: 11300493]
192. Chang JF, Zhao HL, Phillips J, Greenburg G. The epithelial mucin, MUC1, is expressed on resting T lymphocytes and can function as a negative regulator of T cell activation. Cell Immunol 2000; 201: 83-88 [PMID: 10831317 DOI: 10.1006/cimm.2000.1643]
193. Agrawal B, Krantz MJ, Reddish MA, Longenecker BM. Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2. Nat Med 1998; 4: 43-49 [PMID: 9427605]
194. Plate JM, Shott S, Harris JE. Immunoregulation in pancreatic cancer patients. Cancer Immunol Immunother 1999; 48: 270-279 [PMID: 10478644]
195. Pylayeva-Gupta Y, Lee KE, Hajdu CH, Miller G, Bar-Sagi D. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 2012; 21: 836-847 [PMID: 22698407 DOI: 10.1016/j.ccr.2012.04.024]
196. Rasheed ZA, Matsui W, Maitra A. Pathology of pancreatic stroma in PDAC. In: Grippo PJ, Munshi HG, editors. Source Pancreatic Cancer and Tumor Microenvironment. 1st ed. Trivandrum (India): Transworld Research Network, 2012
197. Pandol S, Edderkaoui M, Gukovsky I, Lugea A, Gukovskaya A. Desmoplasia of pancreatic ductal adenocarcinoma. Clin Gastroenterol Hepatol 2009; 7: S44-S47 [PMID: 19896098 DOI: 10.1016/j.cgh.2009.07.039]
198. Ene-Obong A, Clear AJ, Watt J, Wang J, Fatah R, Riches JC, Marshall JF, Chin-Aleong J, Chelala C, Gribben JG, Ramsay AG, Kocher HM. Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma. Gastroenterology 2013; 145: 1121-1132 [PMID: 23891972 DOI: 10.1053/j.gastro.2013.07.025]
199. Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB, Logsdon CD. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 2008; 68: 918-926 [PMID: 18245495]
200. Fujita H, Ohuchida K, Mizumoto K, Egami T, Miyoshi K, Moriyama T, Cui L, Yu J, Zhao M, Manabe T, Tanaka M. Tumor-stromal interactions with direct cell contacts enhance proliferation of human pancreatic carcinoma cells. Cancer Sci 2009; 100: 2309-2317 [PMID: 19735487 DOI: 10.1111/j.1349-7006.2009.01317.x]
201. Kikuta K, Masamune A, Watanabe T, Ariga H, Itoh H, Hamada S, Satoh K, Egawa S, Unno M, Shimosegawa T. Pancreatic stellate cells promote epithelial-mesenchymal transition in pancreatic cancer cells. Biochem Biophys Res Commun 2010; 403: 380-384 [PMID: 21081113 DOI: 10.1016/j.bbrc.2010.11.040]
202. Erkan M, Adler G, Apte MV, Bachem MG, Buchholz M, Detlefsen S, Esposito I, Friess H, Gress TM, Habisch HJ, Hwang RF, Jaster R, Kleeff J, Klöppel G, Kordes C, Logsdon CD, Masamune A, Michalski CW, Oh J, Phillips PA, Pinzani M, Reiser-Erkan C, Tsukamoto H, Wilson J. StellaTUM: current consensus and discussion on pancreatic stellate cell research. Gut 2012; 61: 172-178 [PMID: 22115911 DOI: 10.1136/gutjnl-2011-301220]
203. Tjomsland V, Niklasson L, Sandström P, Borch K, Druid H, Bratthäll C, Messmer D, Larsson M, Spa˚ngeus A. The desmoplastic stroma plays an essential role in the accumulation and modulation of infiltrated immune cells in pancreatic adenocarcinoma. Clin Dev Immunol 2011; 2011: 212810 [PMID: 22190968 DOI: 10.1155/2011/212810]
204. Froeling FE, Feig C, Chelala C, Dobson R, Mein CE, Tuveson DA, Clevers H, Hart IR, Kocher HM. Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt-β-catenin signaling to slow tumor progression. Gastroenterology 2011; 141: 1486-197, 1486-197, [PMID: 21704588 DOI: 10.1053/j.gastro.2011.06.047]
205. Mace TA, Ameen Z, Collins A, Wojcik S, Mair M, Young GS, Fuchs JR, Eubank TD, Frankel WL, Bekaii-Saab T, Bloomston M, Lesinski GB. Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner. Cancer Res 2013; 73: 3007-3018 [PMID: 23514705 DOI: 10.1158/0008-5472.CAN-12-4601]
206. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM. Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006; 66: 9339-9344 [PMID: 16990346]
207. Dorado J, Lonardo E, Miranda-Lorenzo I, Heeschen C. Pancreatic cancer stem cells: new insights and perspectives. J Gastroenterol 2011; 46: 966-973 [PMID: 21698355 DOI: 10.1007/s00535-011-0422-x]
208. Polyak K, Haviv I, Campbell IG. Co-evolution of tumor cells and their microenvironment. Trends Genet 2009; 25: 30-38 [PMID: 19054589 DOI: 10.1016/j.tig.2008.10.012]
209. Jinushi M, Chiba S, Yoshiyama H, Masutomi K, Kinoshita I, Dosaka-Akita H, Yagita H, Takaoka A, Tahara H. Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells. Proc Natl Acad Sci USA 2011; 108: 12425-12430 [PMID: 21746895 DOI: 10.1073/pnas.1106645108]
210. Korkaya H, Liu S, Wicha MS. Regulation of cancer stem cells by cytokine networks: attacking cancer's inflammatory roots. Clin Cancer Res 2011; 17: 6125-6129 [PMID: 21685479 DOI: 10.1158/1078-0432.CCR-10-2743]
211. Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK, Vonderheide RH, Leach SD, Stanger BZ. EMT and dissemination precede pancreatic tumor formation. Cell 2012; 148: 349-361 [PMID: 22265420 DOI: 10.1016/j.cell.2011.11.025]
212. Dodson LF, Hawkins WG, Goedegebuure P. Potential targets for pancreatic cancer immunotherapeutics. Immunotherapy 2011; 3: 517-537 [PMID: 21463193 DOI: 10.2217/imt.11.10]
213. Koos D, Josephs SF, Alexandrescu DT, Chan RC, Ramos F, Bogin V, Gammill V, Dasanu CA, De Necochea-Campion R, Riordan NH, Carrier E. Tumor vaccines in 2010: need for integration. Cell Immunol 2010; 263: 138-147 [PMID: 20434139 DOI: 10.1016/j.cellimm.2010.03.019]
214. Gunturu KS, Rossi GR, Saif MW. Immunotherapy updates in pancreatic cancer: are we there yet? Ther Adv Med Oncol 2013; 5: 81-89 [PMID: 23323149 DOI: 10.1177/1758834012462463]
215. Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J Exp Med 1996; 183: 283-287 [PMID: 8551233]
216. Niccolai E, Prisco D, D'Elios MM, Amedei A. What is recent in pancreatic cancer immunotherapy? Biomed Res Int 2013; 2013: 492372 [PMID: 23509731 DOI: 10.1155/2013/492372]
217. Erkan M, Michalski CW, Rieder S, Reiser-Erkan C, Abiatari I, Kolb A, Giese NA, Esposito I, Friess H, Kleeff J. The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma. Clin Gastroenterol Hepatol 2008; 6: 1155-1161 [PMID: 18639493 DOI: 10.1016/j.cgh.2008.05.006]
218. Bailey JM, Swanson BJ, Hamada T, Eggers JP, Singh PK, Caffery T, Ouellette MM, Hollingsworth MA. Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin Cancer Res 2008; 14: 5995-6004 [PMID: 18829478]
219. Beatty GL, Chiorean EG, Fishman MP, Saboury B, Teitelbaum UR, Sun W, Huhn RD, Song W, Li D, Sharp LL, Torigian DA, O'Dwyer PJ, Vonderheide RH. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science 2011; 331: 1612-1616 [PMID: 21436454 DOI: 10.1126/science.1198443]
220. Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, Seay T, Tjulandin SA, Ma WW, Saleh MN, Harris M, Reni M, Dowden S, Laheru D, Bahary N, Ramanathan RK, Tabernero J, Hidalgo M, Goldstein D, Van Cutsem E, Wei X, Iglesias J, Renschler MF. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 2013; 369: 1691-1703 [PMID: 24131140 DOI: 10.1056/NEJMoa1304369]
221. Nishikawa H, Kato T, Tanida K, Hiasa A, Tawara I, Ikeda H, Ikarashi Y, Wakasugi H, Kronenberg M, Nakayama T, Taniguchi M, Kuribayashi K, Old LJ, Shiku H. CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses. Proc Natl Acad Sci USA 2003; 100: 10902-10906 [PMID: 12947044 DOI: 10.1073/pnas.1834479100]
222. Bazhin AV, Shevchenko I, Umansky V, Werner J, Karakhanova S. Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy. Cancer Immunol Immunother 2014; 63: 59-65 [PMID: 24129765 DOI: 10.1007/s00262-013-1485-8]
223. Finke JH, Rayman PA, Ko JS, Bradley JM, Gendler SJ, Cohen PA. Modification of the tumor microenvironment as a novel target of renal cell carcinoma therapeutics. Cancer J 2013; 19: 353-364 [PMID: 23867518 DOI: 10.1097/PPO.0b013e31829da0ae]
224. Ribeiro RA, Flores CA, Cunha FQ, Ferreira SH. IL-8 causes in vivo neutrophil migration by a cell-dependent mechanism. Immunology 1991; 73: 472-477 [PMID: 1916898]
225. Wolpe SD, Sherry B, Juers D, Davatelis G, Yurt RW, Cerami A. Identification and characterization of macrophage inflammatory protein 2. Proc Natl Acad Sci USA 1989; 86: 612-616 [PMID: 2643119]
226. Bozic CR, Kolakowski LF, Gerard NP, Garcia-Rodriguez C, von Uexkull-Guldenband C, Conklyn MJ, Breslow R, Showell HJ, Gerard C. Expression and biologic characterization of the murine chemokine KC. J Immunol 1995; 154: 6048-6057 [PMID: 7751647]
227. Zhang Y, Ramos BF, Jakschik BA. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science 1992; 258: 1957-1959 [PMID: 1470922]
228. Schmid MC, Avraamides CJ, Foubert P, Shaked Y, Kang SW, Kerbel RS, Varner JA. Combined blockade of integrin-α4β1 plus cytokines SDF-1α or IL-1β potently inhibits tumor inflammation and growth. Cancer Res 2011; 71: 6965-6975 [PMID: 21948958 DOI: 10.1158/0008-5472.CAN-11-0588]
229. Castell JV, Gómez-Lechón MJ, David M, Hirano T, Kishimoto T, Heinrich PC. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 1988; 232: 347-350 [PMID: 2454206 DOI: 10.1016/0014-5793(88)80766-X]
230. Castell JV, Gómez-Lechón MJ, David M, Fabra R, Trullenque R, Heinrich PC. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990; 12: 1179-1186 [PMID: 1699862]
231. Yoshimura T, Yuhki N, Moore SK, Appella E, Lerman MI, Leonard EJ. Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett 1989; 244: 487-493 [PMID: 2465924]
232. Parham P, Janeway C. The immune system. 3rd ed. London, NY: Garland Science, 2009
233. Taga K, Mostowski H, Tosato G. Human interleukin-10 can directly inhibit T-cell growth. Blood 1993; 81: 2964-2971 [PMID: 8499633]
234. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012; 12: 253-268 [PMID: 22437938 DOI: 10.1038/nri3175]
235. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815-3822 [PMID: 1940369]
236. Fujishima S, Hoffman AR, Vu T, Kim KJ, Zheng H, Daniel D, Kim Y, Wallace EF, Larrick JW, Raffin TA. Regulation of neutrophil interleukin 8 gene expression and protein secretion by LPS, TNF-alpha, and IL-1 beta. J Cell Physiol 1993; 154: 478-485 [PMID: 8436597 DOI: 10.1002/jcp.1041540305]
237. Nikolaus S, Bauditz J, Gionchetti P, Witt C, Lochs H, Schreiber S. Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut 1998; 42: 470-476 [PMID: 9616306]
238. Takemura R, Werb Z. Secretory products of macrophages and their physiological functions. Am J Physiol 1984; 246: C1-C9 [PMID: 6364825]
239. Fink GW, Norman JG. Specific changes in the pancreatic expression of the interleukin 1 family of genes during experimental acute pancreatitis. Cytokine 1997; 9: 1023-1027 [PMID: 9417814]
240. Feurino LW, Zhang Y, Bharadwaj U, Zhang R, Li F, Fisher WE, Brunicardi FC, Chen C, Yao Q, Min L. IL-6 stimulates Th2 type cytokine secretion and upregulates VEGF and NRP-1 expression in pancreatic cancer cells. Cancer Biol Ther 2007; 6: 1096-1100 [PMID: 17568185]
241. Jin C, Ni Q, Zhang Q. [Apoptosis of pancreatic acinar and expression of TNF-alpha mRNA, IL-10 mRNA in rats with acute pancreatitis]. Zhonghua Wai Ke Zazhi 2001; 39: 626-628 [PMID: 11758205]
242. Altstaedt J, Kirchner H, Rink L. Cytokine production of neutrophils is limited to interleukin-8. Immunology 1996; 89: 563-568 [PMID: 9014822]
243. Nozawa H, Chiu C, Hanahan D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA 2006; 103: 12493-12498 [PMID: 16891410 DOI: 10.1073/pnas.060180710]
244. Schmielau J, Finn OJ. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. Cancer Res 2001; 61: 4756-4760 [PMID: 11406548]
245. Tazawa H, Okada F, Kobayashi T, Tada M, Mori Y, Une Y, Sendo F, Kobayashi M, Hosokawa M. Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression. Am J Pathol 2003; 163: 2221-2232 [PMID: 14633597]
246. Wasiuk A, Dalton DK, Schpero WL, Stan RV, Conejo-Garcia JR, Noelle RJ. Mast cells impair the development of protective anti-tumor immunity. Cancer Immunol Immunother 2012; 61: 2273-2282 [PMID: 22684520 DOI: 10.1007/s00262-012-1276-7]
247. Roche WR. Mast cells and tumors. The specific enhancement of tumor proliferation in vitro. Am J Pathol 1985; 119: 57-64 [PMID: 3985123]
248. Murai M, Turovskaya O, Kim G, Madan R, Karp CL, Cheroutre H, Kronenberg M. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol 2009; 10: 1178-1184 [PMID: 19783988 DOI: 10.1038/ni.1791]
249. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942-949 [PMID: 15322536]
250. Rajarathnam K, Sykes BD, Kay CM, Dewald B, Geiser T, Baggiolini M, Clark-Lewis I. Neutrophil activation by monomeric interleukin-8. Science 1994; 264: 90-92 [PMID: 8140420]
251. Becker S, Quay J, Koren HS, Haskill JS. Constitutive and stimulated MCP-1, GRO alpha, beta, and gamma expression in human airway epithelium and bronchoalveolar macrophages. Am J Physiol 1994; 266: L278-L286 [PMID: 8166297]